Clinical Trial Update: Open Label Prostate Cancer Study [Phase 1]

View source ↗

Summary

An open-label Phase 1 clinical trial for prostate cancer sponsored by AstraZeneca has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Snippet

Sponsor: AstraZeneca | Conditions: Prostate Cancer | Phase 1 | Status: COMPLETED